Human placental estradiol 170-dehydrogenase (E 2 DH) cDNA clones were isolated from a \gt11 expression library by screening with 33 mer synthetic oligonucleotides derived from the amino acid sequence of the catalytic site of E 2 DH and with polyclonal antibodies raised against the enzyme purified from human placenta. Using 32 P-labeled fragments from the coding and 5'-untranslated regions, two mRNA species have been identified in poly(A) + RNA from human placenta, a major species migrating at 1.3 kilobases (kb) while a minor one is found at 2.2 kb. Primer extension analysis identifies the major mRNA as starting 9-10 nucleotides upstream from the in-frame ATG initiating codon while the longer mRNA has at least 814 noncoding nucleotides at its 5'-terminus. Sequence analysis of the longest cDNA clone (2092 base pairs) shows that this clone possesses identical coding and noncoding sequences in the regions of overlap with the shorter cDNA clones. The 32 P-labeled 5'-noncoding fragment hybridized only to the 2.2 kb band, thus providing additional evidence for the existence of two distinct mRNA species which differ only in their 5'-noncoding regions. Using hpE 2 DH36 cDNA as a probe for in situ hybridization, the human E 2 DH gene was localized to the q11-q12 region of chromosome 17. The cloned cDNAs encode E 2 DH, a 327-amino acid protein having a calculated molecular weight of 34,853. Since E 2 DH is the enzyme required for the formation of 170-estradiol, the availability of the cDNA encoding the enzyme should permit a detailed
INTRODUCTION
Estrogens play a predominant role in the development, growth, and function of all tissues involved in reproduction and fertility in women. In addition, the action of estrogens in promoting the growth of breast cancer ( 1 -3) and a series of other malignant and nonmalignant hormone-sensitive diseases (4, 5) is well recognized. The most important estrogen, 17/3-estradiol, is synthesized from its weak precursor estrone through the action of estradiol 17/3-dehydrogenase (E 2 DH) (EC 1.1.1.62). Despite its recognized key role and its purification to homogeneity two decades ago (6) (7) (8) (9) , the only information available about the structure of E 2 DH was limited to its amino acid composition (10), a 5-amino acid sequence at the NH 2 terminus (10), a heptadecapeptide possibly involved in coenzyme binding (11) and a 20-amino acid sequence at the catalytic site (12) . We report the molecular cloning and sequencing of cDNAs encoding human E 2 DH. The availability of this cDNA offers the opportunity of studying in detail the factors controlling the expression of this crucial enzyme, not only in gonadal but also in several peripheral estrogen target tissues. It should also permit to elucidate the molecular alterations responsible for E 2 DH deficiency in the human and could well lead to the development of inhibitors of estradiol biosynthesis.
RESULTS

Approximately 5 x 10
5 independent recombinants obtained from a human placental Xgt11 cDNA library were screened by hybridization with two 32 P-labeled 33 mer oligonucleotides derived (13) from the amino acid sequence of the catalytic site of E 2 DH (12) . The first screening yielded five positive clones which were isolated and identified as hpE 2 DH6,17,31,36, and 53, respectively. Polyclonal antibodies raised against E 2 DH purified to homogeneity from human placenta by affinity chromatography (Fig. 1) showed cross-reactivity with fusion proteins produced by hpE 2 DH6 and hpE 2 DH31 (Fig. 2B) . A good correlation was observed between the size of the fusion proteins and the length of the corresponding inserts (Fig. 2B ). Clone hpE 2 DH6 contains an insert of 654 base pairs (bp) in length while clone hpE 2 DH31 has an insert of 988 bp.
A second screening of the human placenta Xgt11 cDNA library was performed using hpE 2 DH36 as the probe in order to obtain clones containing longer transcripts. Among 65 clones isolated, three clones which contained 2, 128, and 814 nucleotides 5' to the ATG initiating codon were characterized in detail by a combination of restriction endonuclease mapping and DNA sequence analysis according to the strategy described kDa 206- Human placental homogenate (lane A) and purified E 2 DH (lane B) were separated by NaDodSO 4 /PAGE, electroblotted onto nitrocellulose, treated with rabbit anti-E 2 DH serum diluted 1/1000 and exposed to 125 l-labeled goat anti-rabbit IgG. The autoradiograph was obtained after exposing the filters to Kodak X-OMAT films for 14 h at -8 0 C with intensifying screens.
in Fig. 3 . Clones possessing identical sequences in their overlapping regions are also indicated in Fig. 3 .
The first in-frame ATG codon (designated as position 1 in Fig. 4 ) is located 815 nucleotides from the 5'-end of the longest cDNA (hpE 2 DH216). The predicted amino acid sequence of human E 2 DH is illustrated in Fig. 4 . Translation from the first in-frame AUG codon predicts a protein of 327 amino acids. Translation from the second in-frame AUG codon, on the other hand, would predict a protein of 209 amino acids. The second inframe AUG codon lacks a purine at the critical -3 position of the eukaryotic consensus translation initiation sequence (14) . This, in addition to the unique Nterminal amino acid sequence, indicates that the second in-frame AUG codon does not function as an initiation codon.
This protein contains the 17 and 20 amino acid sequences of the suggested coenzyme binding (11) and catalytic (12) sites, respectively. It also contains the sequence of the 23-amino acid N-terminus determined directly by Edman degradation of the purified enzyme (Fig. 4) . A single amino acid difference between the N-terminal sequence (Ala-Glu-Thr-Val-Val) reported by Burns et al. (10) and the predicted N-terminal amino acid sequence (Ala-Arg-Thr-Val-Val) is observed. An Arg at position 2 from the initiation codon (ATG) is predicted from the cDNAs instead of Glu as previously reported by protein sequencing (10) . These data show that human E 2 DH is 327 amino acids long.
The ATG initiation codon is preceeded at -4 1 by a TATA box-like motif (ATATCAA) (15) (16) (17) and a GC-rich (93%) region at nucleotides -5 1 to -8 0 containing the GC box consensus sequence (GGGGCGGGGC). Analysis of the promoter region of viral and cellular genes has identified the consensus sequence ?GGGGCGGAAT C or its inverted repeat termed the GC box. This consensus sequence has been shown to interact with transcription factor Sp1 and is commonly found in the promoter sequences of housekeeping genes (18, 19) . The GC box present at nucleotides -6 1 to -5 2 could well act as an Sp1-binding site for transcription of the shorter mRNA transcript. There is a putative inverse CAAT box (GATTG)at-101 (20) .
As evidenced by sequencing of the corresponding 5'-flanking region of the human E 2 DH gene, the 5'-noncoding region of the cDNA sequence shown in Fig.  4 (nucleotides -814 to -1) is identical to the genomic nucleotide sequence (Luu-The, V., and F. Labrie, unpublished data). This, to our knowledge, could represent one of the rare examples where one promoter region of a gene is potentially transcribed into a long mRNA transcript of the same gene (21, 22) . Usually, mRNAs having different 5'-noncoding regions originate from alternative tissue splicing (23) .
The sequence CACCATGG containing the initiating codon ATG corresponds to the sequence found as being the optimal sequence for initiation by eukaryotic ribosomes (14) . This strong initiation site allows for efficient translation of the predominant placental mRNA containing only nine to ten 5'-noncoding nucleotides. In the 5'-region, there is no potential in-frame ATG The single open reading frame beginning at the ATG codon (nucleotide 815 of the cDNA) is shown below the nucleotide sequence which is numbered in the 5'-to 3'-direction. Nucleotides are numbered above the sequence while amino acids are numbered below the sequence. Nucleotides 5' of the ATG codon are given negative numbers. The amino acid sequences of the coenzyme binding site (11) , of the catalytic site (12) , as well as the NH 2 -terminus determined from the purified enzyme are underlined. The nucleotides corresponding to the translation stop codon TAA, the putative polyadenylation signal AATAAA, the TATA and inverse CAAT boxes as well as the GC box are also underlined.
initiating codon. There are, however, 10 ATG codons upstream of the true ATG starting codon (14) . The at positions -729, -706, -695, -679, -590, -567, presence of upstream ATG codons could inhibit initia--452, -430, -424, and -415 which could well modution at the proper downstream starting codon (14, 24) . late the efficiency of translation of the long mRNA (14) .
The amino acid composition of the protein deduced Only 5-10% of eukaryotic mRNAs possess ATG triplets from the nucleotide sequence (Table 1 ) is in good agreement with the amino acid composition previously reported (10) . The calculated mol wt of E 2 DH of 34,853 is also in agreement with the mol wt of 33,500 ± 1,000 estimated by NaDodSO 4 /polyacrylamide gel electrophoresis (PAGE) (25) . Ultracentrifugation studies reveal that the enzyme in solution is a dimer of identical subunits of about 68,000 daltons (10, 25) . Clones hpE 2 DH36 and hpE 2 DH248 contain a 3'-untranslated region of 264 nucleotides. A consensus polyadenylation signal AATAAA (26) is located 15 nucleotides upstream of the poly(A) tail.
Using a probe (probe 2) exclusive to the 5'-end of the longest cDNA, it can be seen in Fig. 5A that a mRNA species is detected at 2.2 kb which specifically hybridizes to the unique 5'-probe (Fig. 5A) . However, when the probe corresponding to the coding region is used (probe 1), mRNAs of both 1.3 and 2.2 kilobases (kb) are detected. The present data confirm the presence of two mRNA transcripts differing in size by approximately 1000 bp. While the short mRNA is predominant in placenta, the long form of the mRNA is abundant in other tissues including the breast cancer cell line ZR-75-1, prostate and adrenals (Labrie, C , unpublished data). Moreover, the present data indicate that the difference is due to variable 5'-ends of the transcripts. The mRNA population was further analyzed by primer extension using poly(A) + RNA prepared from human placenta. Using a 17 bp oligonucleotide primer corresponding to positions 92 to 75 of the cDNA, the predominant products obtained by extension with reverse transcriptase are approximately 103 bp long, thus indicating the presence of 9 to 10 nucleotides upstream of the starting ATG codon in this mRNA species.
In order to localize the chromosomal position of the human E 2 DH gene in normal cells, we used the [ 3 H] hpE 2 DH36 clone. In the 168 metaphase cells examined by in situ hybridization, 256 silver grains were associated with chromosomes and 24 of them (9.3%) were located on chromosome 17 (Fig. 6) . The distribution of grains on this chromosome was not random since 50% were located on the q11-q12 region of the long arm with a maximal concentration in the 17q12 band. The present data thus assign the E 2 DH gene to chromosome 17.
Since E 2 DH is well known to be associated with membranes, a hydropathy plot was generated according to the algorithm of Kyte and Doolittle (27) . Such analysis (Fig. 7) predicts that the N-terminal region of E 2 DH is hydrophobic while the C-terminal region is hydrophilic. The hydrophobic region (residues 90 to 200) adjacent to the catalytic site (residues 203 to 223) might be involved in steroid binding.
DISCUSSION
Based on the predicted amino acid sequence of the cDNA clone which contains the 20 amino acid sequence of the catalytic site of E 2 DH (12), an heptadecapeptide possibly involved as coenzyme binding site (11) , and a 23 N-terminal amino acid fragment determined by Edman degradation of the purified enzyme, we can conclude that the present cDNA clones encode E 2 DH. As additional support, polyclonal antibodies raised against the purified enzyme react with the /?-galactosidase fusion proteins produced by cDNA clones (Fig. 2) . Moreover, the mol wt (34.853) and the amino acid composition (Table 1) obtained from the deduced amino acid sequence are in a good agreement with the mol wt (33,500 ± 1,000) and amino acid composition previously reported for the purified enzyme (25) .
There is no evidence for the presence of carbohydrates in the E 2 DH molecule (10) . Accordingly, no consensus sequences corresponding to potential N-glycosylation sites (Asn-X-Ser or Thr) are evident within the E 2 DH open reading frame. After completion of this work, the sequence of a 1325 bp E 2 DH cDNA having a short 5'-noncoding segment has been reported (28) .
In addition to its role in the placenta, special attention has been given to E 2 DH in the endometrium (4) and breast (5) . It is in fact thought that the beneficial effect of treatment with progestins in endometrial cancer is due to the stimulation of E 2 DH activity which increases the formation of inactive estrone from the highly potent 17j8-estradiol (4). E 2 DH is also likely to play a major role in breast development and functions as well as in the growth of breast cancer (3, 4) .
The availability of a full-length cDNA encoding human E 2 DH opens the possibility of studying in detail the mechanisms which control the expression of this enzyme in a large series of tissues already known to
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Nco1 Nco1 display enzymatic activity. Furthermore, this should permit to obtain additional information about the steroid dehydrogenase(s) responsible for the synthesis of androgens in mammalian tissues. Such data should have major implications for a better understanding of the development, growth, and function of the gonadal as well as accessory sex organs. Moreover, such information should be crucial for a better knowledge of the reproductive processes and for the design of specific inhibitors of sex steroid formation which could play a major role in the treatment of sex steroid-dependent cancers, especially breast and endometrial cancer.
MATERIALS AND METHODS
Screening of the Human Placental cDNA Library
A mixture of two oligodeoxyribonucleotide probes of 33 mer (5'-CAG-GTA-CTG-GTA-GAA-ACG-GTG-GAA-[AG]GT-GTG-(aAT-3') predicted (13) from the amino acid sequence of the catalytic site of E 2 DH (12) were synthesized with a Biosearch DNA synthesizer. The purified oligonucleotides were 5'-endlabeled and used as probes to screen the human placental cDNA library (Clontech Laboratories, Inc., Palo Alto, CA). Hybridization was performed at 45 C in 6x SSC (1 x SSC = 0.15 M sodium chloride/0.015 M sodium citrate, pH 7.0), 1 X Denhardt's ( 1 X Denhart's = 0.02% polyvinyl pyrrolidone, 0.02% Ficoll, 0.02% BSA), 100 /*g/ml yeast tRNA and 0.05% sodium pyrophosphate. Filters were washed twice in 3x SSC, 0.05% sodium pyrophosphate at 55 C for 30 min.
SK vector (Stratagene, San Diego, CA) and synthetic oligonucleotides were used as sequencing primers as indicated in Fig. 3 .
RNA Blot Analysis
Total RNA was isolated from human placenta by homogenizing tissue in guanidinium isothiocyanate followed by centrifugation through a cushion of 5.7 M CSCI (34) (35) (36) (37) (38) . Poly(A) + RNA was purified by two successive cycles of chromatography through an oligo(dT>cellulose column (39) . RNA blot analysis was
Lysogen Construction and Immunoblot Analysis
Lysogens of positive Agt11 recombinant clones were generated in the Escherichia coli strain Y 1089 and the /3-galactosidase fusion proteins were prepared as described by Huynh et al. (29) . Cell lysate proteins from each lysogen were separated on 5-15% NaDodSO 4 /PAGE (30) and electroblotted onto nitrocellulose. The protein blots were then washed and treated with rabbit anti-E 2 DH serum and 125 l-labeled goat antirabbit immunoglobulin G (IgG) as described (31) .
DNA Sequencing
Complementary DNA clones were sequenced by the dideoxy chain termination method (32) using modified T7 DNA polymerase ( by arrows) illustrating the specific site of hybridization of the hpE 2 DH36 probe on chromosome 17. C, Same metaphases after subsequent R-banding by fluorochrome photolysis Giemsa method shows that the labeled region is located on q11-q12 subbands.
performed as previously described (37, 38) . Briefly, 20-Mg samples of poly(A) + RNA isolated from human placenta were electrophoresed on a 1.2% agarose/2.2 M formaldehyde gel and immobilized on a nylon membrane (Hybond-N, Amersham, Arlington Heights, IL). Hybridization with either the 588 bp Pst\Sac\ fragment corresponding to a section of the coding sequence of hpE 2 DH36 cDNA (probe 1) or the 823 bp 5'-noncoding EcoRI-A/col-A/col fragment of cDNA hpE 2 DH216 (probe 2) was performed at 42 C for 16 h. The fragments were labeled with [«- 32 P]dCTP to a specific activity of 1 x 10 9 dpm/ fig using the random primer method (40) . The probes were added to hybridization buffer (37) at a concentration of 2 x 10 6 cpm/ml. Three micrograms of BRL (Gaithersburg, MD) 0.24-9.5 kb RNA ladder were blotted alongside the placental poly(A) + RNA and hybridized with 32 P-labeled lambda DNA. The filters were washed twice for 15 min in 2x SSC/0.1% sodium dodecyl sulfate (SDS) at room temperature followed by two 15 min washes in 0.1 x SSC/0.1% SDS at room temperature and two 15-min washes in fresh 0.1 x SSC/0.1% SDS at 65 C. The autoradiograph was obtained after exposing the filters to Kodak X-OMAT AR films for 8.5 h at -8 0 C between two intensifying screens.
Chromosome Localization
In situ hybridization was performed on chromosome preparations obtained from phytohemoglutinin-stimulated human lymphocytes cultured for 72 h as previously described (41). 5-Bromodeoxyuridine was added for the last 7 h of culture (30 Mg/ml) to ensure high quality posthybridization chromosomal banding. The hpE 2 DH36 clone was 3 H-labeled by nick-translation to a specific activity of 1.0 x 10 7 dprn/^g. The labeled probe was hybridized to metaphase spreads at a final concentration of 25 ng/ml hybridization solution as described (41) . After coating with nuclear track emulsion (Kodak NTB 2 ), the slides were exposed for 24 days at 4 C. Subsequently, chromosome spreads were stained with buffered Giemsa solution and the metaphases were photographed. R-Banding was then performed by the fluoro-chrome-photolysis-Giemsa method and metaphases were photographed before analysis.
